|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 536.50 INR | +1.10% |
|
-8.81% | +21.90% |
| 05-22 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 37.36B 386M 339M 315M 290M 544M 553M 3.77B 1.47B 18.22B 1.45B 1.42B 63.22B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 39.47B 408M 358M 333M 306M 574M 585M 3.98B 1.55B 19.25B 1.53B 1.5B 66.79B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +1.39% | ||
| 1 week | -8.81% | ||
| Current month | +15.85% | ||
| 1 month | +24.32% | ||
| 3 months | +44.41% | ||
| 6 months | +46.28% | ||
| Current year | +21.90% |
| 1 week | 523.35 |  | 610.95 |
| 1 month | 424.6 | | 685.95 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 07/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 21/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 09/08/2023 |
| Director/Board Member | 57 | 09/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | -8.81% | -15.35% | +41.65% | 385M | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.48% | +18.87% | +17.81% | 264B | |
| +0.25% | -4.62% | -27.66% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.52% | -0.86% | +21.87% | +49.26% | 355.78B | |
| Weighted average by Cap. | +1.73% | +1.12% | +35.40% | +75.23% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 218M 192M 178M 164M 307M 313M 2.13B 831M 10.3B 818M 801M 35.72B | 22.02B 227M 200M 186M 171M 320M 326M 2.22B 866M 10.74B 854M 835M 37.26B |
| Net income | 1.38B 14.2M 12.49M 11.6M 10.67M 20.01M 20.37M 139M 54.12M 671M 53.31M 52.16M 2.33B | 2.53B 26.11M 22.96M 21.33M 19.62M 36.79M 37.45M 255M 99.5M 1.23B 98.02M 95.9M 4.28B |
| Net Debt | 3.7B 38.23M 33.62M 31.23M 28.73M 53.87M 54.84M 373M 146M 1.81B 144M 140M 6.26B | 2.11B 21.75M 19.13M 17.77M 16.35M 30.66M 31.21M 213M 82.9M 1.03B 81.67M 79.9M 3.56B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ₹536.50 | +1.10% | 774 |
| 23/07/26 | ₹530.65 | +0.54% | 6,967 |
| 22/07/26 | ₹527.80 | -9.92% | 18,859 |
| 21/07/26 | ₹585.95 | -1.52% | 4,911 |
| 20/07/26 | ₹595.00 | +0.86% | 4,385 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
